Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia

NCT01105273 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Aplastic Anemia

Interventions

BIOLOGICAL: anti-thymocyte globulin
BIOLOGICAL: filgrastim
DRUG: Fludarabine
DRUG: Cyclophosphamide
PROCEDURE: CD3±CD19 depleted hematopoietic stem cell transplantation

Sponsor

Asan Medical Center